# Swoop

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/swoop

- Industry: Marketing/Advertising
- Headquarters: Cambridge, US
- Website: www.swoop.com
- Total disclosed funding: $11M
- Latest round: Series B (Nov 12, 2013)
- Investors on record: 3

## About

Swoop Inc. is a US-based company that specializes in omnichannel marketing solutions, employing advanced AI technology to connect healthcare brands with patients and providers across multiple platforms.Swoop Inc. was founded in 2011 in Cambridge, US, focusing on omnichannel marketing strategies for the healthcare sector. The company recently underwent a significant change when it was spun-off from Real Chemistry, with New Mountain Capital acquiring a majority stake in the company. Ron Ellwell, a co-founder and the current CEO, has a history of leading marketing initiatives in the healthcare industry. The company has completed 7 deals as it continues to expand its operations globally, with the most recent deal in September 2024. Swoop has raised a total of USD 2.1 mn in funding, with the latest funding round also amounting to USD 2.1 mn.Swoop provides a comprehensive suite of omnichannel marketing solutions that utilize advanced AI and data analytics. Their offerings include predictive audience targeting, which identifies patients likely to disengage from treatment, alongside omnichannel activation that coordinates messaging at critical clinical decision points. Key products such as Swoop Agents and the HCP Pro suite enhance user engagement through real-time insights tailored for specific disease communities. Primarily serving the pharmaceutical, life sciences, and healthcare marketing sectors, Swoop focuses on the US market while also expanding into regions affected by chronic and rare diseases, collaborating with major partners in programmatic advertising and publishing.Swoop generates revenue from B2B relationships with healthcare brands and marketing agencies, utilizing a business model that includes subscription-based services and partnership agreements. Their marketing solutions, particularly predictive audience targeting, are designed to help clients achieve measurable ROI in their campaigns, effectively increasing patient adherence and brand conversation rates. Pricing plans vary depending on the selected services, catering to the diverse needs of their clientele in the pharmaceutical and healthcare sectors.Following the recent spin-off in September 2024, Swoop Inc. plans to enhance its growth initiatives backed by new funding from New Mountain Capital. The firm aims to introduce upcoming products aimed at further improving patient engagement and treatment adherence. Additionally, Swoop is targeting expansion into new geographic regions where chronic and rare diseases are prevalent, with specific plans for international market penetration set to commence in 2025. The recent funding will bolster these efforts, enabling Swoop to scale its marketing solutions and effectively serve an expanding client base.

## Funding rounds

- Series B, Nov 12, 2013, $3.5M — US Venture Partners
- Series B, Nov 12, 2012, $3M — Valhalla Partners, General Catalyst Partners
- Series A, May 9, 2011, $4.8M — US Venture Partners, Valhalla Partners, General Catalyst Partners

## Investors

- US Venture Partners (https://capitalatlas.ai/funds/us-venture-partners) — Series A, Series B
- Valhalla Partners (https://capitalatlas.ai/funds/valhalla-partners) — Series A, Series B
- General Catalyst Partners (https://capitalatlas.ai/funds/general-catalyst-partners) — Series A, Series B